GlassScriptPhysician profile
Jamie Cochran
NPI 1568061364
$1,896.26
in general payments reported to CMS, 2019-2025
12 companies · $553 in 2025
The $553 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.67 · 2023: $571 · 2024: $679 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.97 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $810.09 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $258.52 | 2023 | Farxiga, Breztri |
| Amgen INC. | $235.90 | 2024 | Tepezza |
| Lilly USA, LLC | $235.22 | 2022-2023 | Mounjaro, Jardiance, Emgality |
| Tandem Diabetes Care, INC. | $118.45 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $92.91 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $43.43 | 2023-2024 | |
| Vbi Vaccine (Delaware) INC. | $29.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.63 | 2023 | Jardiance |
| Exact Sciences Corporation | $18.40 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $16.62 | 2025 | Minimed 780g |
| Abbott Laboratories | $14.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.